Clinicopathological and prognostic implications of genetic alterations in oral cancers

Oncology Letters

Volumn 2, Issue 3, 2011, Pages 445-451

  Pathare, Swapnali M ^a   Gerstung, Moritz ^c   Beerenwinkel, Niko ^c   Schäffer, Alejandro A ^d   Kannan, Sadhana ^a   Pai, Prathamesh ^a   Pathak, K Alok ^e   Borges, Anita M ^b   Mahimkar, Manoj B ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b SL Raheja Hospital   (India)

^c ETH ZURICH   (Switzerland)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e CANCERCARE MANITOBA   (Canada)

Author keywords

Comparative genomic hybridization; Gain of 11q13; Loss of 18q; Oral cancer; Prognosis; Survival analysis

Indexed keywords

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 7P; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME GAIN; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CANCER; NUMERICAL CHROMOSOME ABERRATION; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SMOKING; SURVIVAL RATE; VIRUS DNA CELL DNA INTERACTION; WART VIRUS;

EID: 79953276797     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.271     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Notani P: Epidemiology and prevention of head and neck cancer: a global view. In: Contemporary Issues in Oral Cancer. Saranath D (ed). Oxford University Press, New Delhi, pp1-29, 2000.
3. Nair U, Bartsch H and Nair J: Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19: 251-262, 2004.
4. Akervall J: Genomic screening of head and neck cancer and its implications for therapy planning. Eur Arch Otorhinolaryngol 263: 297-304, 2006.
5. Hermsen M, Joenje H, Arwert F, et al: Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol 33: 414-418, 1997.
6. Wolff E, Girod S, Liehr T, et al: Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncol 34: 186-190, 1998.
7. Weber R, Scheer M, Born I, et al: Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 153: 295-303, 1998.
8. Okafuji M, Ita M, Hayatsu Y, Shinozaki F, Oga A and Sasaki K: Identification of genetic aberrations in cell lines from oral squamous cell carcinomas by comparative genomic hybridization. J Oral Pathol Med 28: 241-250, 1999.
9. Okafuji M, Ita M, Oga A, et al: The relationship of genetic aberrations detected by comparative genomic hybridization to DNA ploidy and tumor size in human oral squamous cell carcinomas. J Oral Pathol Med 29: 226-231, 2000.
10. Oga A, Kong G, Tae K, Lee Y and Sasaki K: Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. Cancer Genet and Cytogenet 127: 24-29, 2001.
11. Lin S, Chen Y, Kao S, et al: Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38: 266-273, 2002.
12. Hannen E, Macville M, Wienk S, et al: Different chromosomal imbalances in metastasized and nonmetastasized tongue carcinomas identified by comparative genomic hybridization. Oral Oncol 40: 364-371, 2004.
13. Noutomi Y, Oga A, Uchida K, et al: Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways. J Pathol 210: 67-74, 2006.
14. Martin C, Reshmi S, Ried T, et al: Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 44: 369-382, 2008.
15. Pathare S, Schäffer A, Beerenwinkel N and Mahimkar M: Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression. Int J Cancer 124: 2864-2871, 2009.
16. D'Souza G, Kreimer AR, Viscidi R, et al: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956, 2007.
17. Gillison ML: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31: 744-754, 2004.
18. Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269, 2008.
19. De Roda Husman AM, Walboomers JM, Meijer CJ, et al: Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 56: 802-806, 1994.
20. Khoja S, Ojwang P, Khan S, Okinda N, Harania R and Ali S: Genetic analysis of HIV-1 subtypes in Nairobi, Kenya. PLoS One 3: e3191, 2008.
21. Manoir SD, Schröck E, Bentz M, et al: Quantitative analysis of comparative genomic hybridization. Cytometry 19: 27-41, 1995.
22. Jeuken J, Sprenger S and Wesseling P: Comparative genomic hybridization: practical guidelines. Diagn Mol Pathol 11: 193-203, 2002.
23. Benjamini Y and Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 57: 289-300, 1995.
24. Cox DR: Regression models and life-tables. J Roy Statist Soc Ser B 34: 187-220, 1972.
25. Schwarz G: Estimating the dimension of a model. Ann Stat 6: 461-464, 1978.
26. Tibshirani R: The Lasso method for variable selection in the Cox model. Statistics in Medicine 16: 385-395, 1997.
27. Park MY and Hastie T: L1-regularization path algorithm for generalized linear models. J Roy Statist Soc Ser B 69: 659-677, 2007.
28. Ha PK, Pai SI, Westra WH, et al: Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8: 1203-1209, 2002.
29. Klussmann JP, Weissenborn SJ, Wieland U, et al: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884, 2001.
30. Klussmann JP, Mooren JJ, Lehnen M, et al: Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15: 1779-1786, 2009.
31. Gebhart E, Ries J, Wiltfang J, Liehr T and Efferth T: Genomic gain of the epidermal growth factor receptor harboring band 7p12 is part of a complex pattern of genomic imbalances in oral squamous cell carcinomas. Arch Med Res 35: 385-394, 2004.
32. Kalyankrishna S and Grandis J: Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24: 2666-2672, 2006.
33. Ishwad C, Shuster M, Bockmuhl U, et al: Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer 80: 25-31, 1999.
34. Zhou X, Temam S, Oh M, et al: Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8: 925-932, 2006.
35. Donnellen R and Chetty R: Cyclin D1 and human neoplasia. J Clin Pathol 51: 1-7, 1998.
36. Staibano S, Migonogua M, Muzio L, Alberti L, Natale E and Lucariello A: Overexpression of cyclin D1, bcl-2, and bax proteins, proliferating cell nuclear antigen, and DNA-ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol 29: 1189-1194, 1998.
37. Angadi P and Krishnapillai R: Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol and Endod 103: 30-35, 2007.
38. Mate J, Ariza A, Aracil C, Lopez D, Isama T and Piteira J: Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with ki-67 labelling index and poor cytoplasmic differentiation. J Pathol 80: 395-399, 1996.
39. Shapex S, Rhee J, Spicer D and Lassar A: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-1024, 1995.
40. Bockmuhl U, Schluns K, Kuchler I, Petersen S and Petersen I: Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157: 369-375, 2000.
41. Wreesmann VB, Shi W, Thaler HT, et al: Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 22: 3965-3972, 2004.
42. Miyamoto R, Uzawa N, Nagaoka S, Nakakuki K, Hirata Y and Amagasa T: Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer 95: 2152-2159, 2002.
43. Pearlstein R, Benninger M, Carey T, et al: Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 21: 333-339, 1998.
44. Takebayashi S, Hickson A, Ogawa T, et al: Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 41: 145-154, 2004.
45. Zhang M, Volpert O, Shi Y and Bouck N: Maspin is an angiogenesis inhibitor. Nat Med 6: 196-199, 2000.
46. Xia W, Lau Y and Hu M: High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19: 2398-2403, 2000.